Wright Medical Group (WMGI) Tops Q4 EPS by 6c, Revenues Beat; Offers FY19 Revenue Guidance

Go back to Wright Medical Group (WMGI) Tops Q4 EPS by 6c, Revenues Beat; Offers FY19 Revenue Guidance

Wright Medical (WMGI) PT Raised to $40 at Jefferies

February 27, 2019 9:06 AM EST

Jefferies analyst Raj Denhoy raised the price target on Wright Medical (NASDAQ: WMGI) to $40.00 (from $35.00) while maintaining a Buy rating.

... More

Wright Medical (WMGI) PT Raised to $38 at Needham & Company

February 27, 2019 8:14 AM EST

Needham & Company analyst Mike Matson raised the price target on Wright Medical (NASDAQ: WMGI) to $38.00 (from $35.00) while maintaining a Buy rating following the company's 4Q report. Revenue was $238.1M vs. consensus of $236.1M. EBITDA was $44.1M vs. consensus of $41.5M, and EPS was $0.11 vs. consensus of $0.05.... More

Wright Medical (WMGI) PT Raised to $34 at Credit Suisse

February 27, 2019 7:58 AM EST

Credit Suisse analyst Matt Miksic raised the price target on Wright Medical (NASDAQ: WMGI) to $34.00 (from $33.00) while maintaining a Outperform rating.

... More

Wright Medical (WMGI) PT Raised to $36 at RBC Capital

February 27, 2019 7:28 AM EST

RBC Capital analyst Glenn Novarro raised the price target on Wright Medical (NASDAQ: WMGI) to $36.00 (from $32.00) while maintaining a Outperform rating.

... More